Barclays PLC (LON:BARC)'s European infrastructure fund management business set to be taken over by 3i Group plc (LON:III).

3i Group plc ("3i"), and funds managed by 3i, announce they have agreed to sell Xellia Pharmaceuticals A/S ("Xellia"), a specialty pharmaceutical group focusing on the development, manufacturing and global commercialization of anti-infective therapies, ...

3i Group Plc logo Investec reaffirmed their hold rating on shares of 3i Group Plc (LON: III) in a research note released on Tuesday morning, Analyst Ratings.

3i Group Plc slipped 1.6% to 356.70 pence after the UK based venture capital firm offered to acquire Barclays Plc's European infrastructure fund business.

Director Deals - 3i Group PLC (III). 17 May 2013 | 14:35pm. StockMarketWire.com - Martine Verluyten, Non Executive Director, bought 10,000 shares in the company on the 16th May 2013 at a price of 343.20p.

3i Group plc ("3i") announces that, on 14 May 2013, Quintiles, the world's largest provider of biopharmaceutical development and commercial outsourcing services, announced the completion of its Initial Public Offering ("IPO") on the New York Stock ...

Since its investment, 3i has played a leading role in supporting the company's international expansion through the establishment of subsidiaries in Germany, France and the UK, which expanded the company's footprint from Sweden and the US.

3i Group plc (III.L) announced the preliminary results for the financial year to 31 March 2013. Profit for the year was 183 million pounds, compared to a loss of 783 million pounds in the prior year.

3i Group Plc (III) and Ares Management LLC are planning to join the surge in issuance of European collateralized loan obligations, according to people with knowledge of the matter.

3i Group PLC (>> 3i Group plc) is taking over the European infrastructure fund management business run by Barclays (>> Barclays PLC) as part of a plan to boost fee income from public-private partnerships and energy investment projects.